Lewis JD - Search Results

1

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.

Van Assche G, Lewis JD, Lichtenstein GR, Loftus EV, Ouyang Q, Panes J, Siegel CA, Sandborn WJ, Travis SP, Colombel JF. Van Assche G, et al. Among authors: lewis jd. Am J Gastroenterol. 2011 Sep;106(9):1594-602; quiz 1593, 1603. doi: 10.1038/ajg.2011.211. Epub 2011 Aug 16. Am J Gastroenterol. 2011. PMID: 21844919 Review.

2

Cancer risk in patients with inflammatory bowel disease.

Lewis JD, Deren JJ, Lichtenstein GR. Lewis JD, et al. Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x. doi: 10.1016/s0889-8553(05)70065-0. Gastroenterol Clin North Am. 1999. PMID: 10372277 Free article. Review.

3

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

Lewis JD, Schwartz JS, Lichtenstein GR. Lewis JD, et al. Gastroenterology. 2000 Jun;118(6):1018-24. doi: 10.1016/s0016-5085(00)70353-2. Gastroenterology. 2000. PMID: 10833475 Free article.

4

Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?

Su CG, Stein RB, Lewis JD, Lichtenstein GR. Su CG, et al. Among authors: lewis jd. Dig Liver Dis. 2000 Aug-Sep;32(6):518-31. doi: 10.1016/s1590-8658(00)80010-9. Dig Liver Dis. 2000. PMID: 11057928 Free article. Review.

5

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD. Lewis JD, et al. Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x. Am J Gastroenterol. 2001. PMID: 11774944

6

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Su C, et al. Among authors: lewis jd. Am J Gastroenterol. 2002 Oct;97(10):2577-84. doi: 10.1111/j.1572-0241.2002.06026.x. Am J Gastroenterol. 2002. PMID: 12385442

7

Colonic dysplasia and cancer in inflammatory bowel disease.

Judge TA, Lewis JD, Lichtenstein GR. Judge TA, et al. Among authors: lewis jd. Gastrointest Endosc Clin N Am. 2002 Jul;12(3):495-523. doi: 10.1016/s1052-5157(02)00014-4. Gastrointest Endosc Clin N Am. 2002. PMID: 12486941 Review.

8

Seasonal variation in flares of inflammatory bowel disease.

Lewis JD, Aberra FN, Lichtenstein GR, Bilker WB, Brensinger C, Strom BL. Lewis JD, et al. Gastroenterology. 2004 Mar;126(3):665-73. doi: 10.1053/j.gastro.2003.12.003. Gastroenterology. 2004. PMID: 14988820

9

An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery.

Lewis JD, Schoenfeld P, Lichtenstein GR. Lewis JD, et al. Clin Gastroenterol Hepatol. 2003 May;1(3):229-36. doi: 10.1053/cgh.2003.50034. Clin Gastroenterol Hepatol. 2003. PMID: 15017495 No abstract available.

10

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

Su C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD. Su C, et al. Among authors: lewis jd. Gastroenterology. 2004 May;126(5):1257-69. doi: 10.1053/j.gastro.2004.01.024. Gastroenterology. 2004. PMID: 15131785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,178 results

Search Page